{"id":"W2793618046","doi":"10.1093/ecco-jcc/jjx180.022","title":"OP023 A phase 3b open-label multicentre study (VERSIFY) of the efficacy of vedolizumab on endoscopic healing in moderately to severely active Crohn’s disease (CD)","year":2018,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Gastroenterology; Internal medicine; Clinical endpoint; Placebo; Infliximab; Surgery; Crohn's disease; Tumor necrosis factor alpha; Immunology; Clinical trial; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781334,0.001773111,0.002308466,0.0004815887,0.0004850289,0.001232217,0.001096764,0.001562476,0.005699991],"category_scores_gemma":[0.0009340383,0.00069521,0.001469573,0.0004367668,0.001046463,0.0008993504,0.0004316087,0.002644047,0.001043228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007361118,"about_ca_system_score_gemma":0.001310109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008646045,"about_ca_topic_score_gemma":0.002601507,"domain_scores_codex":[0.9994809,0.0002533783,0.00002410044,0.00007546822,0.00006520426,0.0001010093],"domain_scores_gemma":[0.9993291,0.0001407689,0.0001314366,0.00004156402,0.00004989033,0.0003072782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8881015,0.03838369,0.002441725,0.001135082,0.0009399952,0.0001583148,0.0001932259,0.0008950488,0.02096779,0.0002770381,0.001984905,0.04452168],"study_design_scores_gemma":[0.7229028,0.2678879,0.005526247,0.00003479292,0.0002194951,0.00009807671,0.00003676302,0.0004929707,0.001276913,0.0001079868,0.001391998,0.00002410481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843199,0.003437443,0.0007712009,0.000436428,0.0002079181,0.005493604,0.002046015,0.000105056,0.003182518],"genre_scores_gemma":[0.9800867,0.002396496,0.002359614,0.001237767,0.0004137123,0.005184514,0.003532917,0.00004080822,0.004747491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005699991,"threshold_uncertainty_score":0.01906836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02497381057132562,"score_gpt":0.3237015192045054,"score_spread":0.2987277086331797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}